Jason Bock previously held leadership roles at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences.

Authors

• Person: Not available Organization: Drug Target Review
  New cell therapy model accelerates cancer treatment development

Sources

• New cell therapy model accelerates cancer treatment development www.drugtargetreview.com Drug Target Review via serper

Referenced by nodes (2)

• UT MD Anderson Cancer Center entity
• Jason Bock entity